Login

Financial Snapshot

Revenue
TTM
$39.72M
Gross Margin
TTM
23.45%
Net Income
TTM
-$1.658M
Current Assets
Last 4 Quarters
N/A
Current Liabilities
Last 4 Quarters
N/A
Current Ratio
Last 4 Quarters
N/A
Total Assets
Total Liabilities
Book Value
2025 Q4
-3.615M cads
Cash
Last 4 Quarters
N/A
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$2.914M

Stock Price

Loading...
Market Cap: $2.47 Million

About IM Cannabis Corp

IM Cannabis Corp. engages in the production and sale of medical cannabis products. The firm's ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The firm also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of its products throughout the entire value chain. In Germany, the Company’s ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. The firm's brands include The Craft Collection, The Top-Shelf Collection, The Signature Collection, The Full Spectrum Extracts, Roma, The WAGNERS, BLKMKT, LOT420, The PICO collection, and Flower.

Industry: Medicinal Chemicals & Botanical Products Peers: Lexaria Bioscience Corp

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support